Materials Science and Nanotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Materials Science and Nanotechnology 44 7897 074717

Rapid Communication - Materials Science and Nanotechnology (2025) Volume 9, Issue 4

Advanced biosensors for rapid poc diagnostics.

Catarina Silva*

Institute of Materials and Nanotechnology, Lisbon University, Portugal

*Corresponding Author:
Catarina Silva
Institute of Materials and Nanotechnology
Lisbon University, Portugal.
E-mail: c.silva@lisbon-nano.example.com

Received : 01-Jul-2025, Manuscript No. AAMSN-25-209; Editor assigned : 03-Jul-2025, PreQC No. AAMSN-25-209(PQ); Reviewed : 23-Jul-2025, QC No AAMSN-25-209; Revised : 01-Aug-2025, Manuscript No. AAMSN-25-209(R); Published : 12-Aug-2025 , DOI : 10.35841/aamsn-9.4.209

Citation: Silva C. Advanced biosensors for rapid poc diagnostics. Mater Sci Nanotechnol. 2025;09(04):209.

Visit for more related articles at Materials Science and Nanotechnology

Introduction

The field of microfluidic biosensors is undergoing rapid transformation, with the latest advancements specifically targeting Point-of-Care (POC) diagnostics. These innovative systems are designed to integrate diverse detection principles and leverage sophisticated material innovations to provide diagnostic solutions that are not only rapid but also cost-effective and highly portable, a necessity for enhancing healthcare accessibility, particularly in regions with limited resources [1].

Simultaneously, researchers are committed to enhancing electrochemical biosensors, with a significant emphasis on refining advanced methods for antibody attachment. The exploration of various functionalization techniques plays a pivotal role in substantially improving both the sensitivity and specificity of these sensors, leading to more reliable and accurate performance across a wide spectrum of diagnostic applications [2].

Integrated systems, such as aptamer- and antibody-modified microfluidic biosensors, are proving highly effective in pathogen detection. These advanced biosensing platforms are capable of delivering rapid, sensitive, and multiplexed analyses, which provides a significant advantage in the timely and accurate diagnosis of infectious diseases [3].

A comprehensive understanding of microfluidic-based electrochemical immunosensors for POC testing has been detailed in recent reviews. These works elucidate the underlying principles governing their operation, various fabrication methodologies, and specific diagnostic applications. The emphasis consistently lies on their considerable potential to offer quick and accurate diagnostic results outside conventional laboratory settings, thereby decentralizing testing capabilities [4].

The development of new functional nanomaterials is pivotal in the continuous improvement of biosensor performance. These materials are instrumental in enhancing the sensitivity and detection limits of diagnostic devices, a progress particularly vital for achieving efficient antibody functionalization, leading to more precise and faster analytical outcomes [5].

The latest advancements in electrochemical biosensors for POC applications underscore their growing importance. These advancements encompass improved designs and innovative materials, collectively contributing to the development of rapid, accurate, and cost-effective diagnostic tools. Their increasing integration into decentralized healthcare systems is crucial for enhancing overall patient outcomes [6].

Further significant progress has been observed in microfluidic platforms specifically engineered for POC diagnostics. These miniaturized systems are expertly designed to handle complex samples and perform analyses using minimal reagents, a capability that significantly accelerates diagnostic workflows and concurrently improves the overall accessibility of essential medical testing [7].

Plasmonic biosensors, especially those skillfully functionalized with antibodies, are revolutionizing the diagnosis of infectious diseases. Their inherent high sensitivity and specificity establish them as robust platforms for the rapid and accurate detection of pathogens directly in clinical settings, a factor fundamental for initiating timely and effective treatments [8].

Recent advancements in microfluidic platforms have also been specifically tailored for immunoassays. These sophisticated systems are engineered to boost assay efficiency, considerably reduce reagent consumption, and facilitate multiplexed detection. Such features are indispensable for high-throughput screening and various POC applications, ultimately leading to more streamlined and efficient diagnostic processes [9].

An overarching review of biosensors in POC diagnostics provides a clear perspective on the current landscape and future trajectories. It meticulously discusses existing challenges while simultaneously highlighting emerging opportunities. The prevailing emphasis is on the imperative need for robust, portable, and user-friendly devices to effectively address and meet evolving global health demands [10].

 

Conclusion

Current research in biosensors centers on developing advanced systems for Point-of-Care (POC) diagnostics, aiming for rapid, cost-effective, and portable solutions. A significant focus lies on microfluidic biosensors, which integrate various detection principles and material innovations to address healthcare accessibility challenges, especially in settings with limited resources. Electrochemical biosensors are also seeing substantial improvements, driven by advanced methods for attaching antibodies. These functionalization techniques boost sensitivity and specificity, making sensors more reliable for diverse diagnostic uses. The integration of aptamers with antibody-modified microfluidic biosensors further enhances pathogen detection, enabling rapid, sensitive, and multiplexed analysis for infectious diseases. Microfluidic electrochemical immunosensors are gaining traction for POC testing, with reviews covering their principles, fabrication, and diagnostic applications. These show promise for delivering quick and accurate results outside traditional labs. New functional nanomaterials are key to improving overall biosensor performance, enhancing sensitivity and detection limits, which directly supports efficient antibody functionalization. The broader field of electrochemical biosensors for POC applications continues to advance, with better designs and materials leading to more accurate and affordable diagnostics. Microfluidic platforms generally are improving, allowing for complex sample handling with minimal reagents, streamlining diagnostic workflows. Antibody-functionalized plasmonic biosensors are also emerging as vital tools for infectious disease diagnosis, offering high sensitivity and specificity for direct clinical use. Microfluidic platforms for immunoassays are becoming more efficient, reducing reagent consumption and enabling multiplexed detection, crucial for high-throughput screening. Looking ahead, the focus for biosensors in POC diagnostics involves addressing challenges and seizing opportunities to create robust, portable, and user-friendly devices to meet global health demands.

References

References

    1. Mengchen W, Ying H, Jinxiang M. Microfluidic-Based Biosensors for Point-of-Care Diagnostics: A Review. Biosens. Bioelectron.. 2024;247:115939.

Indexed at, Google Scholar, Crossref

    1. Xiaoli H, Jian-Hua W, Xing-Hua X. Recent advances in antibody functionalization strategies for electrochemical biosensors. Talanta. 2023;252:123847.

Indexed at, Google Scholar, Crossref

    1. Yuhang H, Kaijie Z, Ming L. Aptamer- and antibody-modified microfluidic biosensors for the detection of pathogens. Biosens. Bioelectron.. 2023;220:114841.

Indexed at, Google Scholar, Crossref

    1. Mahnaz R, Majid S, Narges G. Microfluidic-Based Electrochemical Immunosensors for Point-of-Care Diagnostics: A Comprehensive Review. Biosensors (Basel). 2022;12(8):663.

Indexed at, Google Scholar, Crossref

    1. Yonghao C, Guangxi Z, Kai Z. Recent progress in functional nanomaterials for biosensing applications. Sens. Actuators B Chem.. 2022;367:132147.

Indexed at, Google Scholar, Crossref

    1. Anupriya A, Jyotsna S, Ashish KS. Advances in electrochemical biosensors for point-of-care diagnostics. Anal. Chem. Res.. 2021;34:100494.

Indexed at, Google Scholar, Crossref

    1. Yingying H, Hongying N, Jingfeng M. Advances in microfluidic platforms for point-of-care diagnostics. J. Pharm. Anal.. 2021;11(6):703-717.

Indexed at, Google Scholar, Crossref

    1. Qianqian L, Bo L, Yi W. Antibody-functionalized plasmonic biosensors for infectious disease diagnosis. Biosens. Bioelectron.. 2021;172:112771.

Indexed at, Google Scholar, Crossref

    1. Bo L, Yong-Quan F, Jing-Bo Z. Recent advances in microfluidic platforms for immunoassays. Biosens. Bioelectron.. 2020;154:112061.

Indexed at, Google Scholar, Crossref

    1. Ashutosh T, M. VB, K. RN. Biosensors in point-of-care diagnostics: Current status and future trends. Microchem. J.. 2020;157:104975.

Indexed at, Google Scholar, Crossref

Get the App